Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics.

Endocrinol Diabetes Nutr (Engl Ed) · 2019

Last updated 2026-05-28

Journal	Endocrinol Diabetes Nutr (Engl Ed), 2019
Citations	2
Relative citation ratio	0.06
NIH percentile	5
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction

Full record and abstract on PubMed 30890422 ↗